Latest News for: lla

Edit

LOCAL ROUNDUP: Lady Wreckers notch second straight win over LLA

Standard-Speaker 25 Feb 2021
Bethany Houser and Ashley James combined to make five free throws in the fourth quarter to help the visiting Lady Wreckers hold off Lincoln Leadership Academy for the second straight day. Emma Kane led Weatherly with 12 points, one more than James' 11. Houser finished with seven points, with five coming from the foul line ... LLA (2-8) 2 7 9 6 — 24 ... None.
Edit

Cosmos aim to hold onto top spot as Ea Lla Koto take on wounded Spurs

Supersport 08 Jan 2021
They will be aiming to change all that when they host 15th-placed Free State Stars in the Mother City on Saturday with last season's top goal scorer Abednigo Mosiatlhaga in contention after recovering from injury.</p>Ea Lla Koto got their campaign up and running in ...
Edit

Arrow Exploration Announces Closing of the Sale of the LLA-23 Block (Arrow Exploration Corp)

Public Technologies 30 Dec 2020
LLA-23 Block ... AXL) is pleased to announce the closing of the arm's length disposition (the "Transaction") of the LLA-23 Block to COG Energy Ltd ... Description of LLA-23. The LLA-23 Block is situated in the Llanos Basin, approximately 245 kilometers northeast of Bogotá, the capital city of Colombia.
Edit

BioInvent and Transgene receive CTA approval for Phase l/lla trial of oncolytic virus BT-001 in solid tumors

PR Newswire 21 Dec 2020
TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced they have received regulatory approval in Belgium for a clinical trial application (CTA) for a Phase l/lla study of the novel oncolytic vaccinia virus BT-001.
Edit

BioInvent and Transgene receive CTA approval for Phase l/lla trial of oncolytic virus BT-001 in solid tumors (BioInvent International AB)

Public Technologies 21 Dec 2020
TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced they have received regulatory approval in Belgium for a clinical trial application (CTA) for a Phase l/lla study of the novel oncolytic vaccinia virus BT-001.
  • 1
×